Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Neoplasms 2Brain Neoplasms 2Urinary Bladder Neoplasms 1Respiratory Sounds 1Prostatic Neoplasms 1Pre-Eclampsia 1Postoperative Complications 1Parkinson Disease 1Neuroendocrine Tumors 1Neuroblastoma 1Melanoma 1Lymphoma, Follicular 1Lewy Body Disease 1Leukemia 1Hypoxia 1Hemorrhage 1Edema 1Dyspnea, Paroxysmal 1Dyspnea 1Congenital Hyperinsulinism 1

Interventions

Gemcitabine 87Cisplatin 66Cystectomy 38pembrolizumab 34Docetaxel 25Nivolumab 24durvalumab 21Paclitaxel 19Magnetic Resonance Spectroscopy 18Radiotherapy 17Mitomycin 17Carboplatin 16atezolizumab 15Doxorubicin 14Cystoscopy 14BCG Vaccine 13Surveys and Questionnaires 12Standard of Care 12avelumab 11Sunitinib 10tremelimumab 9Transurethral Resection of Bladder 9Ipilimumab 9Filgrastim 9Blood Specimen Collection 9Specimen Handling 8Neoadjuvant Therapy 8Methotrexate 8Methods 8Early Intervention, Educational 8

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Urinary Bladder Neoplasms × Furosemide × Clear all
NCT02373735 2015-12-30

Effect of SVV Guided Fluid Therapy on Blood Loss and Postoperative Outcomes

Asan Medical Center

Phase NA Completed
64 enrolled
Genitourinary

Urinary Bladder Neoplasms, Hemorrhage, Postoperative Complications

Data powered by HemOnc (CC BY 4.0) Colophon âš¡